Effective patient recruitment for rare disease research

With 350 million people affected worldwide, rare diseases represent a major unmet medical need. However, the timely recruitment of eligible participants is a challenge for any rare disease clinical trial.

Post pandemic clinical trial strategies: How COVID-19 altered clinical trials forever and what’s next

The COVID-19 pandemic forced the clinical trials industry to accept and accelerate the use of digital health technologies.

Encouraging patient participation in real world studies

Real world data offers an alternative approach to observational research, particularly to inform decisions on patient needs and preferences.